NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
DOL’s AI-Ready Initiative Gains Early Traction with Nationwide Rollout
A new seven-day AI course from the Labor Department uses mobile learning to boost AI literacy nationwide.
3m read -
CDC’s AI Strategy Embraces Speed, Flexibility
CDC’s Chief AI Officer Travis Hoppe shares how the agency is aligning cutting-edge tools with federal standards and mission needs.
13m watch -
Building the Military Health System’s AI Ecosystem
DHA and Red Hat discuss building a secure AI ecosystem, strengthening data foundations and ensuring safe AI use in military health care.
31m watch -
White House AI Framework Revives Early Internet Governance Debates
Trump administration’s National AI Legislative Framework echoes Web 1.0 tensions over liability, innovation and federal preemption.
4m read
